Company record
Bon Opus Biosciences delivers recombinant protein and cell‑based production services. Its technical portfolio encompasses recombinant protein expression, large‑scale protein manufacturing, antibody generation, targeted protein modification, and protein crystallization. The company’s product catalogue includes a range of biologics such as interleukins, interferons, chemokines, various enzymes, and specialized proteins involved in cell‑adhesion, stem‑cell function, neurobiology, inflammation, dendritic‑cell activity, and ubiquitination.
This directory record does not yet have a linked material-flow brief.